Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • avo
    Member
    • Sep 2013
    • 14

    AMPure PB / AMPure XP / SPB differences

    Does anyone know what the differences between the AMPure PacBio, AMPure XP or Illumina sample purification beads are? Different PEG concentrations,or if there no differences at all?

    Thanks
  • aerseq
    Junior Member
    • Apr 2014
    • 4

    #2
    AMPure XP beads and AMPure "PB" beads

    AMPure "PB" beads are pre-washed AMPure XP beads. According to the document below from Pacific Biosciences, the AMPure XP beads have a contaminant that elutes simultaneously with your nucleic acids and may interfere with polymerase binding, especially in low quantities of DNA. The supernatant of the AMPure XP beads is replaced after washing the beads.



    See page 16 of 67 in the pdf cited above for the recommended washes. Does anyone know what the contaminant is? I haven't contacted Beckman Coulter regarding this.

    Comment

    • austinso
      Member
      • Jun 2012
      • 77

      #3
      Probably more important for PacBio, but azide is present (as a preservative), and that can affect polymerase activity.

      Comment

      • aerseq
        Junior Member
        • Apr 2014
        • 4

        #4
        Does anyone use brands of SPRI beads (such as MagBio's HighPrep PCR beads) rather than Beckman Coulter's Agencourt AMPure XP beads?

        Comment

        • yeyue
          Junior Member
          • Feb 2018
          • 2

          #5
          Originally posted by aerseq View Post
          Does anyone use brands of SPRI beads (such as MagBio's HighPrep PCR beads) rather than Beckman Coulter's Agencourt AMPure XP beads?
          so AMPure "PB" beads are the same with SPRI beads?

          Comment

          • nucacidhunter
            Jafar Jabbari
            • Jan 2013
            • 1250

            #6
            AMPure PB are specific formulation of AMPure XP for PacBio library clean ups and costs more than XP.

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
              by SEQadmin2


              Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

              The systematic characterization of the human proteome has
              ...
              07-20-2026, 11:48 AM
            • SEQadmin2
              Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
              by SEQadmin2



              Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
              ...
              07-09-2026, 11:10 AM
            • SEQadmin2
              Cancer Drug Resistance: The Lingering Barrier to Rising Survival
              by SEQadmin2



              Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

              There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
              07-08-2026, 05:17 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, Yesterday, 11:41 AM
            0 responses
            9 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-20-2026, 11:10 AM
            0 responses
            23 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-13-2026, 10:26 AM
            0 responses
            36 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-09-2026, 10:04 AM
            0 responses
            45 views
            0 reactions
            Last Post SEQadmin2  
            Working...